I have listened to the call multiple times. What NP

New Post Public Reply Private Reply Replies (1) Message Board
blafarm Heads #35572
649
I have listened to the call multiple times.

What NP effectively said was that it was going to take 2 weeks from today for the last P2 patient's data to be collected anyway. So, in two weeks they are going to assess how far short they are on full enrollment (75). If they are not far away, they will likely stay the course to achieve full enrollment -- because it does make a difference in terms of approval. Conversely, if they are still far away from 75, all parties (internal and external) will discuss the pros and cons of unblinding the trial.

Interestingly, and I believe this is the first time I have heard this from him, he indicated that preliminary results from the P2-3 can provided to the FDA at 50% of enrollment -- not 50 patients as I formerly understood. 50% is 195 patients (390 divided by 2). He then said that after receiving approval for the P2 they would ask the FDA to present interim results from the P2-3 (ostensibly before 195 had been enrolled).

I had been operating under the assumption that preliminary results from the P2-3 could be shared with the FDA based on the first 50 patients. And I think many others on the board believed the same to be true. And yet, no matter how many times I read the trial protocol, I could never find that specification.

It now makes more sense that the metric is 50% and not 50 patients, as I can imagine that might be a standardized approach across a plurality of trials. And I now understand that P2 approval is going to be the driver for providing the FDA with preliminary results from P2-3 before that 50% enrollment number is achieved.
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

SEALSQ Leads the Charge Against Quantum Threats to Bitcoin

Updated Category News Views 115

Quantum-Resistant Innovations by SEALSQ Corp SEALSQ Corp, renowned for its groundbreaking advancements in the realm of Post-Quantum Technology, is taking bold steps to safeguard the future of digital currencies like Bitcoin. The company has unveiled significant developments in quantum-resistant cryptography that aim to mitigate potential vulnerabilities in blockchain...

Continue Reading
Exploring the Impressive Returns of Webster Financial Stock

Updated Category News Views 198

Understanding Webster Financial's Stock Growth Webster Financial (WBS) has demonstrated a commendable performance in the financial market. Over the past five years, the company has outperformed the market, achieving an annualized return of 18.74%, which is 4.31% higher than the broader market average. Investment Outcomes Over The Years For investors considering the...

Continue Reading
Understanding the Importance of Confidentiality in Business Sales

Updated Category News Views 124

Understanding the Importance of Confidentiality in Business Sales In the world of small business sales, maintaining confidentiality is crucial for both buyers and sellers. When owners decide to sell their business, the details surrounding the sale must be handled delicately to ensure that sensitive business information is protected. This is not just about privacy; it's...

Continue Reading
Jeremy Langford Joins Montage Gold's Board of Directors

Updated Category News Views 232

Jeremy Langford Joins Montage Gold's Board of Directors Montage Gold Corp. is excited to announce that Jeremy Langford has been appointed to its Board of Directors. This significant addition marks a proactive step forward in the company’s journey towards becoming a leading multi-asset African gold producer. Expertise That Matters Mr. Langford brings over 20 years of...

Continue Reading
NeurAxis Expands Coverage for PENFS Technology

Updated Category News Views 108

NeurAxis Announces New Medical Coverage for PENFS CARMEL, Ind. — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a prominent player in the medical technology field focusing on neuromodulation, has shared exciting news regarding medical coverage for its groundbreaking treatment, Percutaneous Electrical Nerve Field Stimulation (PENFS)....

Continue Reading